NCT00118170
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
Clinical trial condition
Stage III Mantle Cell Lymphoma
Explore clinical trials studying Stage III Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
44 public trials
0 recruiting studies
Stage III Mantle Cell Lymphoma trial results
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
NCT02797470
- Conditions
- Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +41 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States